Pharmaceutical

Image

Middle East and Africa Pterygium Drug Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Jun 2022
  • MEA
  • 350 Pages
  • No of Tables: 122
  • No of Figures: 53

Middle East and Africa Pterygium Drug Market, By Disease Type (Progressive Pterygium and Atrophic Pterygium), Stages (Stage 2, Stage 3, Stage 1, Stage 4), Treatment (Artificial Tears/Topical Lubricants and Steroid Eye Drops), Formulation (Eye Drops, Eye Ointments, Others), Mode of Purchase (Prescription and Over the Counter (OTC)), Population Type (Geriatric and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others) - Industry Trends and Forecast to 2029.

Middle East and Africa Pterygium Drug Market

Market Analysis and Insights

Pterygium is a common ocular surface lesion that begins in the limbal conjunctiva within the palpebral fissure and progresses to the cornea. It is named after the Greek word pterygos, which means "wing".  The lesion occurs more frequently at the nasal limbus than the temporal with a characteristic wing-like appearance.  UV exposure is strongly linked to the occurrence of pterygia. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could be due to a higher rate of UV exposure.

It can cause redness, inflammation, and a change in the look of the eye; it can create astigmatism, which can cause blurry vision; and it can cause a whitish or pinkish growth covering the front of the eye. It could affect one or both eyes.

Pterygium is diagnosed using a microscope to examine the front components of the eye during a full eye examination and based on the appearance of tissue growth on the cornea from the white area of the eye.

Data Bridge Market Research analyses that the Middle East and Africa pterygium drug market will grow at a CAGR of 3.5% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customisable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Disease Type (Progressive Pterygium and Atrophic Pterygium), Stages (Stage 2, Stage 3, Stage 1, Stage 4), Treatment (Artificial Tears/Topical Lubricants and Steroid Eye Drops), Formulation (Eye Drops, Eye Ointments, Others), Mode of Purchase (Prescription and Over the Counter (OTC)), Population Type (Geriatric and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others)

Countries Covered

South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait and Rest of Middle East and Africa

Market Players Covered

Johnson & Johnson Services, Inc. (U.S.), Novartis AG (Switzerland), Akorn Operating Company LLC (U.S.), Bausch & Lomb Incorporated (Canada), AbbVie Inc. (U.S.),  Prestige Consumer Healthcare Inc. (U.S.), Théa Laboratories (France),  Wellona Pharma (India), Bayer AG (Germany), Zydus Group, Amneal Pharmaceuticals LLC (India), OASIS Medical (U.S.), Alcon (Switzerland), and Santen Pharmaceutical Co., Ltd. (Japan)

Market Definition

Pterygium is a common ocular surface lesion that begins in the limbal conjunctiva within the palpebral fissure and progresses to the cornea. It is named after the Greek word pterygos, which means "wing".  The lesion occurs more frequently at the nasal limbus than the temporal with a characteristic wing-like appearance.  UV exposure is strongly linked to the occurrence of pterygia. Individuals having a history of elevated UV exposure and those living closer to the equator have a higher incidence (outdoor work). According to certain research, males have a somewhat higher incidence than females, which could simply be due to a higher rate of UV exposure.

Pterygium is diagnosed using a microscope to examine the front components of the eye during a full eye examination and based on the appearance of tissue growth on the cornea from the white area of the eye.

Middle East and Africa Pterygium Drug Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • The rise in incidences and prevalences of ophthalmic disorders

According to data published in the National Library of Medicine (National Center for Biotechnology Information) in 2021, the prevalence rates vary in different places. It is most abundant in Cameron's "pterygium belt," which runs between 37° north and south of the equator.

The most common causes of pterygium include long-term exposure to ultraviolet (UV) light from the sun (most common cause) and eye irritation caused by hot, dry weather, wind, and dust. The affirmative factors state that this is the major driver for the global pterygium drugs market.

  • The rise in the geriatric population

With the growing geriatric population across the globe, the prevalence of ophthalmic diseases with severe ocular pain is also growing. According to a data provided published in "Global Prevalence of Blindness and Distance and Near Vision Impairment in 2020: progress towards the Vision 2020 targets and what the future holds" by "The Association for Research in Vision and Ophthalmology" (ARVO) estimated 41.9 million people were blind.

With the growing population, the pressure on the healthcare system is increasing. The demand for care and services is rising to treat the problem of Ophthalmol disorder, including pterygium. Therefore, the increasing geriatric population is a great opportunity for the Middle East and Africa pterygium drug market.

Opportunity

  • Programs and initiatives to reduce the burden of eye diseases

The International agency to prevent blindness has launched several programs and initiatives with well-reputed NGOs and corporates to spread awareness and reduce the burden of eye diseases.

For instance,

  • International Agency endorses our Children's Vision and an initiative co-founded by the Brien Holden Vision Institute and the Vision For Life fund (created by Essilor) for the Prevention of Blindness (IAPB)

Restraint/Challenge

The growing prevalence of various ophthalmic disorders has also increased the necessity for timely treatments. However, the treatments and proper medication for ophthalmology disorders are not very cheap. Recent studies show that the price of topical steroids price is increasing in the past few years. Even though some topical ophthalmic steroids like prednisolone are mildly cheap, other advanced medications and eye drops are still expensive.

Middle East and Africa pterygium drug market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pterygium drug market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The prevalence of ophthalmic disorders keeps showing a surge in growth due to the rise in chemical industries and pollution worldwide. Chemical burns and flash burns cause significant and severe ocular pain due to irritations over the eye surface.

According to data published in the National Library of Medicine (National Center for Biotechnology Information) in 2021, the prevalence rates vary in different places. It is most abundant in Cameron's "pterygium belt," which runs between 37° north and south of the equator. Pterygium prevalence has been reported to range from 0.3 to 29% worldwide.

Middle East and Africa pterygium drug market also provides detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, and adherence are some data variables available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohot multivariate statistical model for forecasting the market in the growth period.

Post COVID-19 Impact on Middle East and Africa Pterygium Drug Market

COVID-19 has negatively affected the market. Lockdowns and isolations during pandemics complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further impact the market.

Recent Development

  • In May 2022, Alcon announced the acquisition of EYSUVIS (loteprednol etabonate suspension) pharmaceutical eye drop from Kala Pharmaceuticals, Inc. The acquisition will complement the company's Systane family of eye drops, including preservative-free formulations.

Middle East and Africa Pterygium Drug Market Scope

Middle East and Africa pterygium drug market is categorized into eight notable segments based on disease type, stages, treatment, formulation, mode of purchase, population type, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

  • Progressive Pterygium
  • Atrophic Pterygium

Based on disease, the Middle East and Africa pterygium drug market is segmented into progressive pterygium and atrophic pterygium.

Stages

  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4

Based on stages, the Middle East and Africa pterygium drug market is segmented into stage 1, stage 2, stage 3, and stage 4.

Treatment

  • Artificial Tears/Topical Lubricants
  • Steroid Eye Drops

Based on treatment, the Middle East and Africa pterygium drug market is segmented into artificial tears/topical lubricants, and steroid eye drops.

Formulation

  • Eye Drops
  • Eye Ointments
  • Others

Based on formulation, the Middle East and Africa pterygium drug market is segmented into eye drops, eye ointments, and others.

Mode of Purchase

  • Prescription
  • Over the Counter (OTC)

Based on mode of purchase, the Middle East and Africa pterygium drug market is segmented into prescription and over-the-counter (OTC).

Population Type

  • Geriatric
  • Adults

Based on population type, the Middle East and Africa pterygium drug market is segmented into geriatric and adults.

End-User

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Based on end-user, the Middle East and Africa pterygium drug market is segmented into hospitals, specialty clinics, home healthcare, and others.

Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Others

Based on distribution channels, the Middle East and Africa pterygium drug market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies.

Middle East and Africa Pterygium Drug Market Regional Analysis/Insights

Middle East and Africa pterygium drug market is analyzed, and market size insights and trends are provided by country, disease type, stages, treatment, formulation, mode of purchase, population type, end-user, and distribution channel. as referenced above.

The countries covered in the Middle East and Africa Middle East and Africa pterygium drug market report are South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait and Rest of Middle East and Africa.

Middle East and African  pterygium drug market are expected to grow due to increased government initiatives to reduce the burden of eye illnesses.

South Africa is expected to dominate the Middle East and Africa pterygium drug market in terms of market share and market revenue. It will continue to flourish its dominance during the forecast period. This is due to the increasing awareness of early diagnosis and treatment of disease

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa Pterygium Drug Market Share Analysis

Middle East and Africa pterygium drug market competitive landscape provides details of the competitor. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, European presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the pterygium drug market.

Some of the major players operating in the Middle East and Africa pterygium drug market are Johnson & Johnson Services, Inc., Novartis AG, Akorn Operating Company LLC, Bausch & Lomb Incorporated, AbbVie Inc., Prestige Consumer Healthcare Inc., Théa Laboratories,  Wellona Pharma, Bayer AG, Zydus Group, Amneal Pharmaceuticals LLC,  OASIS Medical, Alcon, and Santen Pharmaceutical Co., Ltd. among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning grids, Market Time Line Analysis, Market Overview and Guide, Company Positioning grids, Company Market Share Analysis, Standards of Measurement, MEA Vs Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.


SKU-

TABLE 1 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, PIPELINE ANALYSIS

TABLE 2 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA PROGRESSIVE PTERYGIUM IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA ATROPHIC PTERYGIUM IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET , BY STAGES, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA STAGE 2 IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA STAGE 3 IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA STAGE 1 IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA STAGE 4 IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA STEROID EYE DROPS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA STEROID EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA EYE DROPS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA EYE OINTMENTS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA OTHERS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA PRESCRIPTION IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA OVER THE COUNTER (OTC) IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA GERIATRICS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA ADULTS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA HOSPITALS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA HOME HEALTHCARE IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA OTHERS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA RETAIL PHARMACIES IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA HOSPITAL PHARMACIES IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA ONLINE PHARMACIES IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA OTHERS IN PTERYGIUM DRUG MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 50 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 51 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 52 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 53 SOUTH AFRICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 SOUTH AFRICA STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 SOUTH AFRICA KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 57 SOUTH AFRICA EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 58 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 59 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 60 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 61 SOUTH AFRICA PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 62 EGYPT PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 63 EGYPT PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 64 EGYPT PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 65 EGYPT ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 EGYPT STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 67 EGYPT KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 68 EGYPT PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 69 EGYPT EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 70 EGYPT PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 71 EGYPT PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 72 EGYPT PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 73 EGYPT PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 74 ISRAEL PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 75 ISRAEL PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 76 ISRAEL PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 77 ISRAEL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 ISRAEL STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 ISRAEL KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 ISRAEL PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 81 ISRAEL EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 82 ISRAEL PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 83 ISRAEL PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 84 ISRAEL PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 ISRAEL PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 86 UAE PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 87 UAE PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 88 UAE PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 89 UAE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 90 UAE STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 91 UAE KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 92 UAE PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 93 UAE EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 94 UAE PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 95 UAE PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 96 UAE PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 UAE PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 98 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 99 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 100 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 101 SAUDI ARABIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 SAUDI ARABIA STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 SAUDI ARABIA KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 105 SAUDI ARABIA EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 106 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 107 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 108 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 109 SAUDI ARABIA PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 110 KUWAIT PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

TABLE 111 KUWAIT PTERYGIUM DRUG MARKET, BY STAGES, 2020-2029 (USD MILLION)

TABLE 112 KUWAIT PTERYGIUM DRUG MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 113 KUWAIT ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 114 KUWAIT STEROIDS EYE DROPS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 115 KUWAIT KETONE STEROIDS IN PTERYGIUM DRUG MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 KUWAIT PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 117 KUWAIT EYE DROPS IN PTERYGIUM DRUG MARKET, BY FORMULATION, 2020-2029 (USD MILLION)

TABLE 118 KUWAIT PTERYGIUM DRUG MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)

TABLE 119 KUWAIT PTERYGIUM DRUG MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)

TABLE 120 KUWAIT PTERYGIUM DRUG MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 121 KUWAIT PTERYGIUM DRUG MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 122 REST OF MIDDLE EAST AND AFRICA PTERYGIUM DRUG MARKET, BY DISEASE TYPE, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials